60例静脉滴注盐酸胺碘酮致急性肝损害病例分析

摘要/Abstract

摘要： 目的总结静脉滴注胺碘酮致急性肝损害的病例特点，分析其发生的原因和机制，并探讨防治办法。方法对我院2011年发生的1例以及1988～2012年国内外文献报道的59例静脉滴注胺碘酮后出现急性肝损害患者的基本情况、基础疾病、胺碘酮应用指征及使用方法、肝功能损害特点及其他器官功能、合并用药情况以及转归等进行分析。结果急性肝损害前静脉滴注胺碘酮剂量为193.2～4 310（1 345.7±550.6）mg，用药至发现肝损害的时间为6～96（34.0±17.9）h，天冬氨酸氨基转移酶峰值为122.3～17 471（3 798±3 982）U?L-1，丙氨酸氨基转移酶峰值为225～12 426（3 206±1 788）U?L-1。停用胺碘酮注射液及常规肝脏辅助治疗后，52例患者肝酶降至正常的平均时间为21.6±13.24 d，4例因急性肾功能不全或多脏器功能衰竭死亡，1例因肝性脑病死亡，3例因心源性休克死亡。15例患者改为口服胺碘酮，肝功能继续趋于好转。结论静脉胺碘酮急性肝损害的发生与胺碘酮用药总量及疗程之间的关系暂不明确，而高浓度的助溶剂聚山梨醇酯80是导致急性肝损害最关键的因素。存在其他器官损害的急性肝损害患者预后较差，在治疗早期同时启动静脉制剂与口服制剂便于急性肝损害的处理。当合并急性肾功能衰竭时死亡率高，及早进行连续性血液净化（CBP）有利于救治。

关键词: 胺碘酮, 急性肝损害, 静脉滴注, 不良反应。

Abstract: Objective To conclude intravenous infusion of amiodarone-induced acute hepatic injury cases, to analyze the causal factors and mechanisms of acute hepatic injury induced by intravenous infusion of amiodarone, and to find the way of prevention and treatment of acute hepatic injury. Methods The clinical feature, primary disease, indications and Methods of using amiodarone, characteristics of hepatic injury and functions of other organs, concomitant medicines and prognosis of patients were analyzed in 60 cases. One of the cases was the inpatient of our hospital in 2011, and the others were collected from foreign and domestic medical journals between 1988 to 2012. Results The dosage of intravenous amiodarone was 193.2～4 310(1 345.7±550.6)mg, the duration of administration was 6～29(34.0±17.9)h. The peak of AST was 122.3～17 471(3 798±3 982)U?L-1 and ALT was 225～12 426(3 206±1 788)U?L-1. After discontinuation of intravenous amiodarone and conventional liver adjuvant therapy, 52 cases of liver enzymes returned to normal, the average time was 21.6 ± 13.24 d, 4 cases died of acute renal failure or multi-organ failure, one case died of hepatic encephalopathy, three cases died of cardiogenic shock. The liver function of 15 cases who adopted oral amiodarone after stopping intravenous amiodarone continued to improve. Conclusion The relationship between incidence of acute liver injury induced by intravenous amiodarone and the total does of amiodarone, and the treatment time is unclear. However,the high concentration of cosolvent polysorbate 80 is the most critical factors to lead to acute liver injury. The patient with both acute liver injury and other organs damage would have poor prognosis. Intravenous infusion of amiodarone could be safely replaced by oral amiodarone when acute hepatic injury happened. Acute hepatic injury with acute renal failure induced high mortality, CBP is conducive to treatment as soon as possible.

Key words: amiodarone, acute hepatotoxicity, intravenous administration, adverse reactions

中图分类号:

R965

毛敏,徐小华,赵嘉澍,毛建生,杜金行,陆进. 60例静脉滴注盐酸胺碘酮致急性肝损害病例分析[J]. 中国药物警戒, 2015, 12(6): 347-351.

MAO Min,XU Xiao-hua,ZHAO Jia-shu,MAO Jian-sheng,DU Jin-hang,LU Jin. Analysis of 60 Cases of Acute Hepatic Injury Induced by Intravenous Infusion of Amiodarone[J]. Chinese Journal of Pharmacovigilance, 2015, 12(6): 347-351.

参考文献

[1] 徐国帆,陈聪,叶海鹏,等.静脉应用胺碘酮致急性肝损害及其转归[J].河北医学,2007,13(5):578-580.
[2] 殷振华,范莹,吴硕东,等.可达龙致肝功能衰竭、DIC抢救成功一例[J].实用药物与临床,2011,14(2):176-177.
[3] 刘淑萍.静脉滴注胺碘酮致肝损害1例[J].临床荟萃,2008,23(8):551.
[4] 芦涤,金鹏.静脉胺碘酮致急性肝衰竭1例[J].临床荟萃,2007,22(9): 660.
[5] 邵惠霞.静脉注射胺碘酮引起肝损害2例[J].临床荟萃,2009,24(21): 1913.
[6] 王晓彤,丁峰.静脉胺碘酮引起肝损伤3例报告[J].临床心血管病杂志,2009,25(1):77-78.
[7] 孙云川,王家伟,杨毅,等.盐酸胺碘酮注射液短期致4例急性肝损害的临床分析[J].临床药物治疗杂志,2012,10(4):60-62.
[8] 付谦,付娟,饶正伟,等.静脉注射胺碘酮引起肝损害二例分析[J].实用心脑肺血管病杂志,2010,18(6):824.
[9] 刘志红,刘红彬,张晓华,等.胺碘酮静脉滴注致肝损害1例[J].现代中西医结合杂志,2009,18(24):2965-2966.
[10] 温伟,纪立伟,张新超,等.胺碘酮静脉滴注致急性肝损害15例临床分析[J].药物不良反应杂志,2006,8(2):105-109.
[11] 衣淑珍,王爱丽,杨峥维,等.胺碘酮静脉滴注致严重肝损害[J].药物不良反应杂志,2008,10(2):137-138.
[12] 兰安杰,褚燕琦,刘丽宏,等.胺碘酮致心动过缓、低血压及严重肝损害[J].药物不良反应杂志,2010,12(2):137-139.
[13] 杨铁城,李建国,于东明,等.静脉胺碘酮引发致死性肝衰竭两例分析[J].中国急救复苏与灾害医学杂志,2011,06(2):165-166.
[14] 李莉,杨俊,丁家望,等.胺碘酮致急性肝损伤一例[J].中华心血管病杂志,2008,36(5):464.
[15] 张满娣.盐酸胺碘酮致严重急性肝损害1例[J].中国药物警戒,2009, 6(10):630.
[16] 崔向丽,栗云明,黄佳,等.注射用胺碘酮引起急性肝功能衰竭1例[J].中国药物应用与监测,2009,6(2):126-127.
[17] 张战文,赵智琛,刘沙,等.静脉应用胺碘酮致严重肝功能衰竭一例[J].中国心血管病研究,2012,10(6):477-478.
[18] 尹春琳,魏嘉平,汪家瑞,等.静脉胺碘酮致药物性肝损害一例[J].中国医师杂志,2011,02(z2):228-229.
[19] 张立志.胺碘酮注射液致急性肝损害1例[J].中国医药导报,2012,09 (13):101-102.
[20] 李崇剑,周宪梁,张沛,等.静脉用胺碘酮致严重肝功能损害一例[J].中华心律失常学杂志,2004,8(4):251-251.
[21] 曲直立,王丽萍,陈丽,等.静脉应用胺碘酮同时引起肝肾损害1例[J].中国医师进修杂志,2008,31(7):7.
[22] 侯翠红,楚建民,王国干,等.静脉应用胺碘酮致急性肝损害六例临床分析[J].中华心律失常学杂志,2007,11(2):126-128.
[23] 韦志军,黄桂波,蓝四海,等.胺碘酮致低血压及严重肝损害一例[J].华夏医学,2012,25(1):96-97,125.
[24] Goldschlager N, Epstein A E, Naccarelli G V,et al. A practical guide for clinicians who treat patients with amiodarone:2007[J].Heart Rhythm 2007, 4(9):1250-9.
[25] Goldschlager N, Epstein A E, Naccarelli G V, et al. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology[J].Arch Intern Med[J],2000,160(12):1741-8.
[26] Vorperian V R, Havighurst T C, Miller S, et al. Adverse effects of low dose amiodarone: a meta-analysis[J]. J Am Coll Cardiol,1997, 30(3):791-8.
[27] Desai A D, Chun S, Sung R J. The role of intravenous amiodarone in the management of cardiac arrhythmias[J]. Ann Intern Med,1997, 127(4):294-303.
[28] Scheinman M M, Levine J H, Cannom D S, et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias.The Intravenous Amiodarone Multic-enter Investigators Group[J]. Circulation, 1995, 92(11):3264-72.
[29] Podrid P J. Amiodarone: reevaluation of an old drug[J]. Ann Intern Med, 1995, 122(9):689-700.
[30] Gallik D M, Singer I, Meissner M D, et al. Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone[J]. Am J Cardiol, 2002, 90(9):964-8.
[31] Rhodes A, Eastwood J B, Smith S A. Early acute hepatitis with parenteral amiodarone：A toxic effect of the vehicle[J].Gut,1993,34(4):565-6.
[32] Reuter H D, Vitamins I, Beeley L, et al. Side effects of drugs annual 12[M].Amsterdam:Elsevier,1988:327-331.
[33] 黄兴福,杨艳敏,朱俊,等.静脉胺碘酮与严重肝功能损害[J].中国心脏起搏与心电生理杂志,2009,23(6):477-479.
[34] 饶跃峰,郑飞跃,张幸国,等.药物性肝损伤的免疫学机制[J].中国药学杂志,2008,43(16):1207-1210.
[35] Tisdale J E, Follin S L, Ordelova A, et al.Risk factors for the development of specific noncardiovascular adverse effects associated with amiodarone[J].J Clin Pharmacol, 1995,35(4):351-356.
[36] Oesterheld J R, Osser D N. P-450 Drug interactions Program,online version 1.34 ed. Lexington[M],MA:Mental Health Connections,Inc,1997- 2004.
[37] Mohamed B, Samuel S L, Timothy P. Amiodarone Hepatotoxicity[J].Cur Vas Pharmacol,2008,6(3):228-236.
[38] Auletta C S，Reynolds D L，Kelly C M，et a1．Adverse effects of Tween 80 in dogs．Fundam Appl Toxicol,1996,30:101.
[39] 郑策,梅丹,王兰,等.关注制剂中辅料的不良反应[J].中国药学杂志,2005,40(9):644-649.